awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33404027-AFE20A76-CA97-4355-B022-863ADD159591
Q33404027-AFE20A76-CA97-4355-B022-863ADD159591
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33404027-AFE20A76-CA97-4355-B022-863ADD159591
Phase I/II study of sorafenib in combination with temsirolimus for recurrent glioblastoma or gliosarcoma: North American Brain Tumor Consortium study 05-02.
P2860
Q33404027-AFE20A76-CA97-4355-B022-863ADD159591
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33404027-AFE20A76-CA97-4355-B022-863ADD159591
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ee7215dc826088f3a7e7f690fd5a63c8da3058d4
P2860
Sorafenib exerts anti-glioma activity in vitro and in vivo.